JP2015520229A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520229A5
JP2015520229A5 JP2015518386A JP2015518386A JP2015520229A5 JP 2015520229 A5 JP2015520229 A5 JP 2015520229A5 JP 2015518386 A JP2015518386 A JP 2015518386A JP 2015518386 A JP2015518386 A JP 2015518386A JP 2015520229 A5 JP2015520229 A5 JP 2015520229A5
Authority
JP
Japan
Prior art keywords
amount
composition
administered
vitamin
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015518386A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520229A (ja
Filing date
Publication date
Priority claimed from US13/530,673 external-priority patent/US9040082B2/en
Application filed filed Critical
Publication of JP2015520229A publication Critical patent/JP2015520229A/ja
Publication of JP2015520229A5 publication Critical patent/JP2015520229A5/ja
Pending legal-status Critical Current

Links

JP2015518386A 2012-06-22 2012-11-30 神経心理学的障害の治療用の組成物および方法 Pending JP2015520229A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/530,673 2012-06-22
US13/530,673 US9040082B2 (en) 2011-06-24 2012-06-22 Compositions and methods for treatment of chronic fatigue
PCT/US2012/067347 WO2013191724A1 (en) 2012-06-22 2012-11-30 Compositions and methods for treatment of neuropsychological deficits

Publications (2)

Publication Number Publication Date
JP2015520229A JP2015520229A (ja) 2015-07-16
JP2015520229A5 true JP2015520229A5 (https=) 2015-12-17

Family

ID=49769962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015518386A Pending JP2015520229A (ja) 2012-06-22 2012-11-30 神経心理学的障害の治療用の組成物および方法

Country Status (6)

Country Link
US (2) US9040082B2 (https=)
EP (1) EP2879495A4 (https=)
JP (1) JP2015520229A (https=)
AU (1) AU2012382949A1 (https=)
CA (1) CA2849968A1 (https=)
WO (1) WO2013191724A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
JP5973073B2 (ja) 2013-11-08 2016-08-23 イーライ リリー アンド カンパニー アトモキセチン溶液
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
US12472158B2 (en) 2019-02-27 2025-11-18 Vanderbilt University Methods of treating trigeminal nerve pain
CN118076346A (zh) * 2021-07-08 2024-05-24 Nls制药股份公司 用于治疗慢性疲劳综合症和肌痛性脑脊髓炎/慢性疲劳综合症(me/cfs)的拉氟酰胺及其衍生物

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542123A (en) 1982-01-11 1985-09-17 Massachusetts Institute Of Technology Composition and method for increasing brain tyrosine levels
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5096712A (en) 1990-03-06 1992-03-17 Interneuron Pharmaceuticals, Inc. Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety
US5292538A (en) 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
JP2001511153A (ja) 1997-02-04 2001-08-07 ブイ. コスバブ,ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
US6048846A (en) 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
US20030206895A1 (en) 1998-11-13 2003-11-06 Sigma-Tau Healthscience S.P.A. Antioxidant composition comprising propionyl L-carnitine and a flavonoid against throm-bosis and atherosclerosis
CA2373605A1 (en) 1999-05-07 2000-11-16 Trustees Of Tufts College Immune stimulating dietary supplement and methods of use thereof
CA2377414A1 (en) 1999-06-15 2000-12-21 John D. Potter Nutrient formulations for disease reduction, and related treatment and component screening methods
US6103756A (en) 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
WO2001026642A2 (en) * 1999-10-08 2001-04-19 Joyce Corinne Bechthold Methods and compositions for treating neurobehavioral disorders
US20020155163A1 (en) 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US6458384B2 (en) 2000-02-23 2002-10-01 Impetus Ag Pharmaceutical with predetermined activity profile
US6579544B1 (en) 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet
US6423349B1 (en) 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
US20070117869A1 (en) 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
WO2005000203A2 (en) 2001-10-31 2005-01-06 Sention, Inc. Methods for treating cognitive impairment and improving cognition
US6733797B1 (en) 2000-11-15 2004-05-11 William K. Summers Neuroceutical for improving memory and cognitive abilities
US20020193323A1 (en) 2000-11-22 2002-12-19 Inna Yegorova Compositions and methods for promoting a healthy cardiovascular system and enhancing blood flow
US6300377B1 (en) 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
CA2445512C (en) 2001-04-25 2010-10-12 Cobalz Limited A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
US20020165281A1 (en) * 2001-04-26 2002-11-07 Assa Weinberg Treatment of anoxic encephalophathy by administration of N-acetylcystein
AU2002329590B2 (en) 2001-07-11 2006-10-19 Mynd Analytics, Inc. Electroencephalography based systems and methods for selecting therapies and predicting outcomes
US6541043B2 (en) 2001-08-28 2003-04-01 Dexgen Pharmaceuticals, Inc. Method and synergistic composition for treating attention deficit/hyperactivity disorder
US20030049272A1 (en) 2001-08-30 2003-03-13 Yatindra Joshi Pharmaceutical composition which produces irritation
WO2003028747A1 (en) 2001-10-04 2003-04-10 Harris Dennis H Ingestible nerve and circulatory nutritional formulation
EP1304048B1 (en) 2001-10-22 2004-09-22 Ivo Pera Composition to reduce or quit smoking addiction
GB2381451A (en) 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
AU2003228603A1 (en) 2002-04-22 2003-11-10 Rtc Research And Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
US7585523B2 (en) 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
US7968125B2 (en) 2003-04-08 2011-06-28 Janeel Henderson Energy generating composition
US20070237834A1 (en) 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
US20050058672A1 (en) 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
CA2567746A1 (en) * 2003-05-23 2005-01-06 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment and improving cognition
US8211873B2 (en) 2003-08-29 2012-07-03 Island Kinetics, Inc. Antiaging chirally-correct mitoprotectant amino acid and peptide complexes
EP1706146B1 (en) 2003-12-31 2013-08-21 K-Pax Pharmaceuticals, Inc. Nutrient compositions and use thereof for enhanced effectiveness of the immune system
WO2006029411A2 (en) 2004-09-09 2006-03-16 Yeda Research And Development Co. Ltd. Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
CA2589260A1 (en) 2004-11-29 2006-06-01 Aloecorp, Inc. Dehydration of food combinations
US7250181B2 (en) 2005-01-19 2007-07-31 Natreon, Inc. Polyherbal compositions and methods for treating viral infections
US7776915B2 (en) 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
WO2006112283A1 (ja) * 2005-04-13 2006-10-26 Riken Vitamin Co., Ltd. 抗疲労剤
US20060257502A1 (en) 2005-05-11 2006-11-16 Jiankang Liu A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders
US7645742B2 (en) 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
US7893070B2 (en) 2005-08-15 2011-02-22 Provimi Holding B.V. Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
US7976879B2 (en) 2005-11-04 2011-07-12 Roizen Michael F Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions
JP4904795B2 (ja) * 2005-12-06 2012-03-28 大正製薬株式会社 疲労改善剤組成物
JP5174004B2 (ja) 2006-03-13 2013-04-03 ザ ハーシー カンパニー 浸漬ココア組成物及びそれらから作製された機能性ココア飲料
US7972633B2 (en) 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
EP2433655A3 (en) 2007-02-08 2013-05-15 Kempharm, Inc. Homoarginine-prodrugs of amphetamine
US8187647B2 (en) 2008-06-13 2012-05-29 BioClinical Development, Inc. Edible energy composition
WO2009098697A1 (en) 2008-02-08 2009-08-13 Dexxon Ltd. Modafinil and sildenafil dosage forms
EP2259782A4 (en) 2008-03-03 2013-01-23 Nad Life Pty Ltd PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHOD FOR THEIR USE IN THE TREATMENT OF CELL DISEASES
US20090325999A1 (en) 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2331088A4 (en) 2008-08-06 2011-10-12 Gosforth Ct Holdings Pty Ltd COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
US8642095B2 (en) 2008-09-30 2014-02-04 Visalus Holdings, Llc Dietary composition and method of using the same
WO2011087755A2 (en) 2009-12-22 2011-07-21 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
JP5811545B2 (ja) * 2010-06-24 2015-11-11 国立研究開発法人理化学研究所 疲労のバイオマーカーおよびその利用
JP6054301B2 (ja) 2010-12-23 2017-01-11 アマゼンティス エスアーAmazentis Sa ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue

Similar Documents

Publication Publication Date Title
JP2015520229A5 (https=)
JP2014522817A5 (https=)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
UY35624A (es) Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington
FI3478712T3 (fi) Anti-N3pGlu beeta-amyloidipeptidi -vasta-aineita ja niiden käyttöjä
JP2014509659A5 (https=)
JP2010270124A5 (https=)
RU2017119222A (ru) Нейро-аттенуирующие кетаминовые и норкетаминовые соединения, их производные и способы их получения
JP2015529234A5 (https=)
EA201491606A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
BR112014005389A8 (pt) Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal
JP2014512354A5 (https=)
HK1200716A1 (zh) 使用胞苷類似物的口服製劑治療癌症的方法
JP2013509411A5 (https=)
JP2014500295A5 (https=)
BR112012016460A2 (pt) diazóxido ou um sal farmaceuticamente aceitável deste e método para sua utilização no tratamento de uma doença desmielinizante autoimune do sistema nervoso central (cns), e composição farmacêutica.
EA201790406A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
BR112014003704A2 (pt) moduladores ror gama
JP2020534270A5 (https=)
JP2013518914A5 (https=)
EA201270071A1 (ru) Способ лечения пациента, нуждающегося в аспириновой терапии
JP2014512355A5 (https=)
JP2016507500A5 (https=)
JP2016509601A5 (https=)